Cycrin
This medicine is utilized to manage hormonal conditions like endometriosis and is indicated to support the regulation of the menstrual cycle in women.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Alternative names
Provera
- Therapeutic class
Progestogen
- Pharmacological class
Progesterone
- Minor side effects
headache; nausea; dizziness
- Moderate side effects
weight gain; breast tenderness; insomnia
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
1–3 hours
- Duration
24 hours
- Storage instructions
Store at room temperature, away from moisture and direct light.
- Drug interactions
aminoglutethimide
- Age restrictions
Not recommended for paediatric patients.
Contraindications
hypersensitivity to medroxyprogesterone; undiagnosed vaginal bleeding; severe hepatic impairment; pregnancy
Precautions and warnings
risk of venous thromboembolism; use with caution in patients with history of depression; may cause irregular bleeding patterns; monitor hepatic function
Serious side effects
anaphylaxis — requires immediate medical attention; venous thromboembolism — requires immediate medical attention
Patient summary
This medicine is utilized to manage hormonal conditions like endometriosis and is indicated to support the regulation of the menstrual cycle in women.
Mechanism of action
Medroxyprogesterone is a synthetic progestogen that acts on the endometrium, transforming proliferative endometrium into secretory endometrium. It effectively inhibits the production of pituitary gonadotropins, which prevents follicular maturation and ovulation, thereby supporting management of specific reproductive healthcare needs.
Pregnancy and breastfeeding
Pregnancy: Do not use during pregnancy. Breastfeeding: Use with caution as it may be excreted in breast milk.
Cycrin
This medicine is utilized to manage hormonal conditions like endometriosis and is indicated to support the regulation of the menstrual cycle in women.
Editorial Notes
- Active ingredient(s): Medroxyprogesterone
- Listed indication(s): Secondary Amenorrhea, Endometriosis, Dysfunctional Uterine Bleeding
Usually available as
- 180 tablets - 5 mg630-5-mg-2616
- 90 tablets - 10 mg630-10-mg-2620